TECHNICAL ANALYSIS
ISRG
Intuitive Surgical
TECHNICAL RATING
TECHNICAL SCORE
72 / 100
Summary
Price sits 7.5% above the 20-day moving average (420.59), 14.2% above the 50-day (396.06) and 3.7% above the 200-day (436.21), with a Death cross noted in the longer-term cross state. Momentum is confirming the move: MACD is above its signal line and the 14-day RSI is 70.8, in overbought territory as it continues to rise. The stock has broken above the upper Bollinger band and volume is running above its 20-day average, which supports conviction in the breakout while flagging higher short-term volatility. Watch for a decisive failure back inside the upper band and a drop toward the 20-day average, which would weaken this setup.
Price & Moving Averages
Volume
RSI (14)
MACD (12/26/9)
Formula & Methodology
Short-term trendPrice vs. 20-day moving average (weight 10%)
Intermediate trendPrice vs. 50-day moving average (weight 15%)
Long-term regimePrice vs. 200-day moving average (weight 25%)
Cross state50/200 Golden or Death cross (weight 10%)
Momentum + trendMACD 12/26/9 vs signal line (weight 15%)
Momentum bandsRSI (14) state (weight 10%)
VolatilityBollinger-band position (weight 5%)
ConfirmationVolume vs 20-day average (weight 10%)
Rating ruleFormula: the Technical Score is a weighted composite of eight inputs. Trend inputs — price vs. the 20-day (10%), 50-day (15%), and 200-day (25%) moving averages, and the 50/200 Golden or Death cross state (10%) — carry roughly 60% of the weight. Momentum inputs — MACD (12/26/9) vs. its signal line (15%) and RSI (14) state (10%) — carry 25%. Bollinger-band position (5%) and volume vs. the 20-day average (10%) round out the remainder. Each input contributes +1, 0, or -1, weights are re-normalized when a component is unavailable, and the weighted sum is thresholded at +/-0.45 to Bullish, Neutral, or Bearish.
Data Source
Market data sourced from Tiingo. End-of-day prices and volume power the charts and indicators (MA20/50/200, RSI, MACD, Bollinger Bands, Volume) on this page. This page is informational analysis, not investment advice. See Financial Disclaimer.